Drugs for Stroke Recovery: The Example of Amphetamines

Drugs and Aging

Volumn 21, Issue 2, 2004, Pages 67-79

  Martinsson, Louise ^a,b   Eksborg, Staffan ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; AMPHETAMINE DERIVATIVE; DEXAMPHETAMINE; FIBRINOLYTIC AGENT; FLUOXETINE; LEVODOPA; METHAMPHETAMINE;

ATTENTION DEFICIT DISORDER; BRAIN INJURY; CLINICAL PRACTICE; CLINICAL TRIAL; DEATH; DOPAMINE RELEASE; DOSE RESPONSE; DRUG DESIGN; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; FOLLOW UP; HEMIPLEGIA; HUMAN; LONG TERM POTENTIATION; META ANALYSIS; METABOLISM; MORTALITY; MOTOR DYSFUNCTION; NARCOLEPSY; NERVE CELL PLASTICITY; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; NORADRENALIN RELEASE; PHYSIOTHERAPY; PLASMA HALF LIFE; PRIORITY JOURNAL; REVIEW; SEROTONIN RELEASE; SIDE EFFECT; STROKE; TREATMENT OUTCOME;

AMPHETAMINES; ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBROVASCULAR ACCIDENT; HUMANS; META-ANALYSIS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 1442335411     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200421020-00001     Document Type: Review

References (125)

1. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Recommendations on stroke prevention, diagnosis, and therapy. Stroke 1989; 20: 1407-31
2. Warlow CP, Dennis MS, van Gijn J, et al. Stroke: a practical guide to management. Oxford, England: Blackwell Science Ltd, 2001
3. Musolino R, Granata A, La Spina P, et al. Ischaemic stroke in young people: a prospective and long-term follow-up study. Cerebrovasc Dis 2003; 15: 121-8
4. Hart RG, Miller VT. Cerebral infarction in young adults: a practical approach. Stroke 1983; 14: 110-4
5. Kolominsky-Rabas PL, Weber M, Gefeller O, et al. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke 2001; 32: 2735-40
6. Duncan PW, Goldstein LB, Matchar D, et al. Measurement of motor recovery after stroke: Outcome assessment and sample size requirements. Stroke 1992; 23: 1084-9
7. Tatemichi TK, Desmond DW, Stern Y, et al. Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities. J Neurol Neurosurg Psychiatry 1994; 57: 202-7
8. Pedersen PM, Jorgensen HS, Nakayama H, et al. Aphasia in acute stroke: incidence, determinants, and recovery. Ann Neurol 1995; 38: 659-66
9. Pedersen PM, Jorgensen HS, Nakayama H, et al. Hemineglect in acute stroke: incidence and prognostic implications. The Copenhagen Stroke Study. Am J Phys Med Rehabil 1997; 76: 122-7
10. Appelros P, Karlsson GM, Seiger Å, et al. Neglect and anosognosia after first-ever stroke: incidence and relationship to disability. J Rehabil Med 2002; 34: 215-20
11. Turney TM, Garraway WM, Whisnant JP. The natural history of hemispheric and brainstem infarction in Rochester, Minnesota. Stroke 1984; 15: 790-4
12. Kotila M, Waltimo O, Niemi M-L, et al. The profile of recovery from stroke and factors influencing outcome. Stroke 1984; 15: 1039-44
13. Jørgensen HS, Nakayama H, Raaschou HO, et al. Outcome and time course of recovery in stroke: Part I. outcome. The Copenhagen Stroke Study. Arch Phys Med Rehabil 1995; 76: 399-405
14. Schlaug G, Siewert B, Benfield A, et al. Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke. Neurology 1997; 49: 113-9
15. Furlan M, Marchal G, Viader F, et al. Spontaneuos neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol 1996; 40: 216-26
16. Schwamm LH, Koroshetz WJ, Sorensen AG, et al. Time course of lesion development in patients with acute stroke: serial diffusion- and hemodynamic-weighted magnetic resonance imaging. Stroke 1998; 29: 2268-76
17. Chollet F, DiPiero V, Wise RJS, et al. The functional anatomy of motor recovery after stroke in humans: a study with positron emission tomography. Ann Neurol 1991; 29: 63-71
18. Weiller C, Chollet F, Fristen KJ, et al. Functional reorganization of the brain in recovery from striatocapsular infarction in man. Ann Neurol 1992; 31: 463-72
19. Nudo RJ, Milliken GW. Reorganization of movement representations in primary motor cortex following focal ischemic infarcts in adult squirrel monkeys. J Neurophysiol 1996; 75: 2144-9
20. Byrnes ML, Thickbroom GW, Phillips BA, et al. Long-term changes in motor cortical organisation after recovery from subcortical stroke. Brain Res 2001; 889: 278-87
21. Frost SB, Barbay S, Friel KM, et al. Reorganization of remote cortical regions after ischemic brain injury: a potential substrate for stroke recovery. J Neurophysiol 2003; 89: 3205-14
22. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997; 349: 1269-76
23. Peltonen M, Stegmayr B, Asplund K. Time trends in long-term survival after stroke. The Northern Sweden multinational monitoring of trends and determinants in cardiovascular disease (MONICA) study, 1985-1994. Stroke 1998; 29: 1358-65
24. Marini C, Triggiani L, Cimini N, et al. Proportion of older people in the community as a predictor of increasing stroke incidence. Neuroepidemiology 2001; 20: 91-5
25. Kaste M, Fogelholm R, Rissanen A. Economic burden of stroke and the evaluation of new therapies. Public Health 1998; 112: 103-12
26. Marchai G, Beadouin V, Rioux P, et al. Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET-CT study with voxel-based data analysis. Stroke 1996; 27: 599-606
27. Wardlaw JM, del Zoppo G, Yamaguchi T. Thrombolysis for acute ischemic stroke. Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 2. Oxford: Update Software, 2000: CD000213
28. Gladstone DJ, Black SE, Hakim AM, on behalf of the Heart and Stroke Foundation of Ontario Centre of Excellence in Stroke Recovery. Toward wisdom from failure: lessons from neuro-protective stroke trials and new therapeutic directions. Stroke 2002; 33: 2123-36
29. Scheidtmann K, Fries W, Müller F, et al. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study. Lancet 2001; 358: 787-90
30. Pariente J, Loubinoux I, Carel C, et al. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol 2001; 50: 718-29
31. Nishino K, Sasaki T, Takahashi K, et al. The norepinephrine precursor L-threo-3,4-dihydoxyphenylserine facilitates motor recovery in chronic stroke patients. J Clin Neurosci 2001; 8: 547-50
32. Grade C, Redford B, Chrostowski J, et al. Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study. Arch Phys Med Rehabil 1998; 79: 1047-50
33. Walker-Batson D, Curtis S, Natarajan R, et al. A double-blind placebo-controlled study of the use of amphetamine in the treatment of aphasia. Stroke 2001; 32: 2093-8
34. Walker-Batson D, Smith P, Curtis S, et al. Amphetamine paired with physical therapy accelerates motor recovery after stroke: further evidence. Stroke 1995; 26: 2254-9
35. Crisostomo EA, Duncan PW, Propst M, et al. Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann Neurol 1988; 23: 94-7
36. Martinsson L, Wahlgren NG. Safety of dexamphetamine in acute ischemic stroke: a randomized, double-blind, controlled dose-escalation trial. Stroke 2003; 34: 475-81
37. Feeney DM. Mechanisms of noradrenergic modulation of physical therapy: effects on functional recovery after cortical injury. In: Goldstein LB, editor. Restorative neurology: advances in pharmocotherapy for recovery after stroke. New York: Futura Publishing Company Inc, 1998: 35-40
38. Gladstone DJ, Black SE. Enhancing recovery after stroke with noradrenergic pharmacotherapy: a new frontier? Can J Neurol Sci 2000; 27: 97-105
39. Huffman BB. Catecholamines sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman J, Limbird I, editors. The pharmacological basis of therapeutics. New York: McGraw-Hill, 2001: 215-68
40. Sloviter RS, Drust EG, Connor JD. Evidence that serotonin mediates some behavioral effects of amphetamine. J Pharmacol Exp Ther 1978; 206: 348-52
41. Kornetsky C. The pharmacology of the amphetamines. Semin Psychiatry 1969; 1: 227-35
42. MICROMEDEX T. MICROMEDEX (R) Healthcare Series Vol. 114 Expires 12/ 2002, 2002
43. Rang HP, Dale MM, Ritter JM. Central nervous system stimulants and psychotomimetic drugs: pharmacology. 4th ed. Edinburgh: Churchill Livingstone, 1999: 606
44. Sonde L, Nordström M, Nilsson C-G, et al. A double-blind placebo-controlled study of the effects of amphetamine and physiotherapy after stroke. Cerebrovasc Dis 2001; 12: 253-7
45. Mazagri R, Shuaib A, McPehrson M, et al. Amphetamine failed to improve motor function in acute stroke [abstract]. Can J Neurol Sci 1995; 22 Suppl. 1: S25
46. Reding MJ, Solomon B, Borucki S. Effects of dextroamphetamine on motor recovery after stroke [abstract]. Neurology 1995; 45 Suppl. 4: A222
47. Vachalathiti R, Asavallobh C, Nilanont Y, et al. Comparison of physical therapy and physical therapy with amphetamine in sensorimotor recovery of acute stroke patients: randomised controlled trial [abstract]. J Neurol Sci 2001; 187 Suppl. 1: S253
48. Boyeson MG, Feeney DM. Intraventricular norepinephrine facilitates motor recovery following sensorimotor cortex injury. Pharmacol Biochem Behav 1990; 35: 497-501
49. Boyeson MG, Harmon RL, Jones JL. Comparative effects of fluoxetine, amitriptyline and serotonin on functional motor recovery after sensorimotor cortex injury. Am J Phys Med Rehabil 1994; 73: 76-83
50. Feeney DM, Weisend MP, Kline AE. Noradrenergic pharmacotherapy, intracerebral infusion and adrenal transplantation promote functional recovery after cortical damage. J Neural Transplant Plast 1993; 4: 199-213
51. Feeney DM, Gonzales A, Law WA. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science 1982; 217: 855-7
52. Sutton RL, Feeney DM. α-Noradrenergic agonists and antagonists affect recovery and maintenance of beam-walking ability after sensorimotor cortex ablation in the rat. Restor Neurol Neurosci 1992; 4: 1-11
53. Dunn-Meynell A, Pan S, Levin B. Focal traumatic brain injury causes widespread reductions in rat brain norepinephrine turnover from 6 to 24 h. Brain Res 1994; 660: 88-95
54. Finklestein S, Campbell A, Baldessarinin RJ, et al. Late changes in cerebral monoamine metabolism following focal ventrolateral cerebrocortical lesions in rats. Brain Res 1985; 344: 205-10
55. Prasad MR, Ramaiah C, McIntosch TK, et al. Regional levels of lactate and norepinephrine after experimental brain injury. J Neurochem 1994; 63: 1086-94
56. Goldstein LB. McMillan V. Acute unilateral sensorimotor injury in the rat blocks d-amphetamine induced norepinephrine release in the cerebellum. Restor Neurol Neurosci 1993; 5: 371-7
57. Boyeson MG, Krobetr KA, Scherer PJ, et al. Reinstatement of motor deficits in recovered brain-injured animals: the role of cerebellar norepinephrine. Restor Neurol Neurosci 1993; 5: 283-90
58. Bickford P. Aging and motor learning: a possible role for norepinephrine in cerebellar plasticity. Rev Neurosci 1995; 6: 35-46
59. Dam M, Tonin P, De Boni A, et al. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 1996; 27: 1211-4
60. Queen SA, Chen MJ, Feeney DM. d-Amphetamine attenuates decreased cerebral glucose utilization after unilateral sensorimotor cortex contusion in rats. Brain Res 1997; 777:42-50
61. Sutton RL, Hovda DA, Chen MJ, et al. Alleviation of brain injured-induced cerebral metabolic depression by amphetamine: a cythochrome oxidase histochemistry study. Neural Plast 2000; 7: 109-25
62. Stroemer RP, Kent TA, Hulsebosch CE. Enhanced neocortical neural sprouting, synaptogenesis and behavioral recovery with d-amphetamine therapy after neocortical infarction in rats. Stroke 1998; 29: 2381-95
63. Porrino LJ, Lucignani G, Dow-Edwards D, et al. Correlation of dose-dependent effects of acute amphetamine administration on behavior and local cerebral metabolism in rats. Brain Res 1984; 307: 311-20
64. Soetens E, Casaer S, D'Hooge R. Effect of amphetamine on long-term retention of verbal material. Psychopharmacology (Berl) 1995; 119: 155-62
65. Gold PE, Delanoy RL, Merrin J. Modulation of long-term potentiation by peripherally administered amphetamine and epinephrine. Brain Res 1984; 305: 103-7
66. Feeney DM, Hovda DA. Amphetamine and apomorphine restore tactile placing after motor cortex injury in the cat. Psychopharmacology (Berl) 1983; 79: 67-71
67. Feeney DM, Baron J-C. Diaschisis. Stroke 1986; 17: 817-30
68. Feeney DM. Pharmacologic modulation of recovery after brain injury: a reconsideration of diaschisis. J Neurol Rehabil 1991; 5: 113-28
69. Delanoy RL, Tucci DL, Gold PE. Amphetamine effects on long term potentiation in dentate granule cells. Pharmacol Biochem Behav 1983; 18: 137-9
70. Brown TH, Chapman PF, Kairiss EW, et al. Long-term synaptic potentiation. Science 1988; 242: 724-8
71. Sawaki L, Cohen LG, Classen J, et al. Enhancement of use-dependent plasticity by d-amphetamine. Neurology 2002; 59: 1262-4
72. Bütefisch CM, Davis BC, Sawaki L, et al. Modulation of use-dependent plasticity by d-amphetamine. Ann Neurol 2002; 51: 59-68
73. Knecht S, Imai T, Kamping S, et al. D-amphetamine does not improve outcome of somatosensory training. Neurology 2001; 57: 2248-52
74. Mailing HM, Acheson GH. Righting and other postural activity in low-decerebrate and in spinal cats after D-amphetamine. J Neurophysiol 1946; 9: 379-86
75. Dietrich WD, Alonso O, Busto R, et al. Influence of amphetamine treatment on somatosensory function of the normal and infarcted rat brain. Stroke 1990; 21 Suppl. III: III-147-III-150
76. Feeney DM, Sutton RL, Boyeson MG, et al. The locus-coerulus and cerebral metabolism: recovery of function after cortical injury. Physiol Psych 1985; 13: 197-203
77. Schmanke T, Barth TM. Amphetamine and task-specific practice augment recovery of vibrissae-evoked forelimb placing after unilateral sensorimotor cortical injury in the rat. J Neurotrauma 1997; 14: 459-68
78. Goldstein LB, Davis JN. Post-lesion practice and amphetamine-facilitated recovery of beam-walking in the rat. Restor Neurol Neurosci 1990; 1: 311-4
79. Hurwitz BE, Dietrich WD, McCabe PM, et al. Amphetamine promotes recovery from sensory-motor integration deficit after thrombotic infarction of the primary somatosensory rat cortex. Stroke 1991; 22: 648-54
80. Schmanke TD, Avery RA, Barth TM. The effects of amphetamine on recovery of function after cortical damage in the rat depend on the behavioral requirements of the task. J Neurotrauma 1996; 13: 293-307
81. Hovda DA, Feeney DM. Amphetamine with experience promotes recovery of locomotor function after unilateral frontal cortex injury in the cat. Brain Res 1984; 298: 358-61
82. Sutton RL, Hovda DA, Feeney DM. Amphetamine accelerates recovery of locomotor function following bilateral frontal cortex ablation in cats. Behav Neurosci 1989; 103: 837-41
83. Feeney DM, Hovda DA. Reinstatement of binocular depth perception by amphetamine and visual experience after visual cortex ablation. Brain Res 1985; 342: 352-6
84. Boyeson MG, Feeney DM. Adverse effects of catecholaminergic agonists, and antagonists on recovery of locomotor ability following unilateral cerebellar ablations. Restor Neurol Neurosci 1991; 3: 227-33
85. Dose JM, Dhillon HS, Maki A, et al. Lack of delayed effects of amphetamine, methoxamine, and prozosin (adrenergic drugs) on behavioral outcome after lateral fluid percussion brain injury in the rat. J Neurotrauma 1997; 14: 327-37
86. Mintz M, Tomer R. Exposure to amphetamine after substantia nigra lesion interferes with the process of behavioral recovery. Pharmacol Biochem Behav 1986; 25: 1307-11
87. Nudo RJ, Milliken GW, Jenkins WM, et al. Use-dependent alterations of movement representations in primary motor cortex of adult squirrel monkeys. J Neurosci 1996; 16: 785-807
88. Elbert T, Pantev C, Wienbruch C, et al. Increased cortical representation of the fingers of the left hand in string players. Science 1995; 270: 305-7
89. Karni A, Meyer G, Jezzard P, et al. Functional MRI evidence for adult motor cortex plasticity during motor skill learning. Nature 1995; 377: 155-8
90. Classen J, Liepert J, Wise SP, et al. Rapid plasticity of human cortical movement representation induced by practice. J Neurophysiol 1998; 79: 1117-23
91. Jang SH, Kim Y-H, Cho S-H, et al. Cortical reorganization induced by task-oriented training in chronic hemiplegic stroke patients. Neuroreport 2003; 14: 137-41
92. Musso M, Weiller C, Kiebel S, et al. Training-induced brain plasticity in aphasia. Brain 1999; 122: 1781-90
93. Plautz EJ, Milliken GW, Nudo RJ. Effects of repetitive motor training on movement representations in adult squirrel monkeys: role of use versus learning. Neurobiol Learn Mem 2000; 74: 27-55
94. Peto R. Why do we need systematic overviews of randomized trials? Stat Med 1987; 6: 233-40
95. Volpe BT, Shelton F, Krebs HI, et al. Dextroamphetamine paired with standard and robotic neurorehabilitation changes motor performance one day later [abstract]. Ann Neurol 2000; 48: 454
96. Ziegler W, Müller U. Amphetamine in apraxia of speech. International Congress on Stroke Rehabilitation; 1993 Nov 21-24; Berlin. Berlin: German Society for Neurological Rehabilitation, 1993
97. McNeil MR, Doyle PJ, Spencer KA, et al. A double-blind, placebo-controlled study of pharmacological and behavioral treatment of lexical-semantic deficitis in aphasia. Aphasiology 1997; 11: 385-400
98. Benson DF. Presentation 10 - Aphasia therapy [abstract]. In: Benton AL, editor. New York: Harper & Row, 1970: 77
99. Niklasson B. Recovery of motor function after stroke: balance agnosia and amphetamine [abstract]. Eur J Neurosci 1992; Suppl. 5: 212
100. Walker-Batson D, Unwin H, Curtis S, et al. Use of amphetamine in the treatment of aphasia. Restor Neurol Neurosci 1992; 4: 47-50
101. Walker-Batson D, Curtis S, Wolf T, et al. Administration of amphetamine treatment accelerates recovery from aphasia. Brain Lang 1996; 55: 27-9
102. Wongjitrat C, Vachalathiti R, Chaisevikul R, et al. The pilot study of the effect of physical therapy with amphetamine in sensorimotor recovery of acute stroke patients [in Thai]. Siriraj Hosp Gaz 1996; 48: 577-84
103. Martinsson L, Hårdemark H-G, Wahlgren NG. Amphetamines for improving recovery after stroke. Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 3. Oxford: Update Software, 2003)
104. Treig T, Werner C, Sachse M, et al. No benefit from D-amphetamine when added to physiotherapy after stroke: a randomized, placebo-controlled study. Clin Rehabil 2003; 17: 590-9
105. Collen FM, Wade DT, Bradshaw CM. Mobility after stroke: reliability of measures of impairment and disability. Int Disabil Stud 1990; 12: 6-9
106. Cote R, Battista RN, Wolfson C, et al. The Canadian Neurological Scale: validation and reliability assessment. Neurology 1989; 39: 638-43
107. Risedal A, Zeng J, Johansson BB. Early training may exacerbate brain damage after focal brain ischemia in the rat. J Cereb Blood Flow Metab 1999; 19: 997-1003
108. Humm JL, Kozlowski DA, James DC, et al. Use-dependent exacerbation of brain damage occurs during an early post-lesion vulnerable period. Brain Res 1998; 783: 286-92
109. Britton M, Carlsson A, de Faire U. Blood pressure course in patients with actue stroke and matched controls. Stroke 1986; 17: 861-4
110. Unwin H, Walker-Batson D. No side effects after low-dose amphetamine administration in stroke rehabilitation. Stroke 2000; 31: 1788-9
111. Fugl-Meyer AR, Jääskö L, Leyman I, et al. The post-stroke hemiplegic patient: 1. a method for evaluation of physical performance. Scand J Rehabil Med 1975; 7: 13-31
112. Lindmark B, Hamrin E. Evaluation of functional capacity after stroke as a basis for active intervention: validation of a modified chart for motor capacity assessment. Scand J Rehabil Med 1988; 20: 111-5
113. Lindmark B, Hamrin E. Evaluation of functional capacity after stroke as a basis for active intervention: presentation of a modified chart for motor capacity assessment and its reliability. Scand J Rehabil Med 1988; 20: 103-9
114. Gelmers HJ, Gorter K, de Weerdt CJ, et al. A controlled trial of nimodipine in acute ischemic stroke. N Engl J Med 1988; 318: 203-7
115. Porch B. Porch index of communicative ability. California: Consulting Psychologists Press, 1967
116. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J 1965; 14: 61-5
117. Sulter G, Steen C, De Keyser J. Use of the Barthel Index and modified rankin scale in acute stroke trials. Stroke 1999; 30: 1538-41
118. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in ischemic stroke: background and study protocol. Stroke 1985; 16: 855-90
119. Zung WWK. A self-rating depression scale. Arch Gen Psychiatry 1965; 12: 63-70
120. Duncan PW, Jorgensen HS, Wade DT. Outcome measures in acute stroke trials: a systematic review and some recommendations to improve practice. Stroke 2000; 31: 1429-38
121. Beckett AH, Rowland M. Urinary excretion kinetics of amphetamine in man. J Pharm Pharmacol 1965; 17: 628-39
122. Brauer LH, Ambre J, De Wit H. Acute tolerance to subjective but not cardiovascular effects of d-amphetamine in normal, healthy men. J Clin Psychopharmacol 1996; 16: 72-6
123. Shappell SA, Kearns GL, Valentine JL, et al. Chronopharmacokinetics and chronopharmacodynamics of dextroamphetamine in man. J Clin Pharmacol 1996; 36: 1051-63
124. Wong YN, Wang L, Hartman L, et al. Comparison of the single-dose pharmacokinetics and tolerability of modafinil and dextroamphetamine administered alone or in combination in healthy male volunteers. J Clin Pharmacol 1998; 38: 971-8
125. Martinsson L, Xin Y, Beck O, et al. Pharmacokinetics of dexamphetamine in acute stroke. Clin Neuropharmacol 2003; 26: 270-6